Several platforms will be used based on the experience of some of the technological base to support all other associated institutions, are those based on the synthesis of magnetic or fluorescent semiconductor nanoparticles (UFU / UFMG / UFAL / UFPB), either by microfluidics technology (UFAL), or by the use of electrochemical (UFU / UFAL), or by the development of hybrid nanobiossistemas with all technologies available for biophotonics and electrochemical (UFU / UFAL). In all cases seek to develop systems based on new nanobiotecnológicos selected biomarkers aimed at improving or developing new biological in vitro diagnostic precision or in vivo imaging systems with new fluorophores functionalized sensors. 

Although the aim is to obtain new pharmacological nanoformulations for drug delivery and vaccine (UFU / UFMG / IPEN / UFPB) in order to improve control of various infectious and parasitic diseases. In this context, the same molecules applied in diagnostics, high performance are also selected for therapeutic use which characterizes the name of this INCT in Teranóstica and nano-biotechnology, which is the combined use of biomarkers and methods for nanobiotecnológicos both ends.